Ticker: KPTI

Company: Karyopharm Therapeutics Inc.

Person: Richard A Paulson, director, officer

Transaction date: May 6, 2025

Reporting date: May 7, 2025

Average share price: 7.12

Sold 236.0 shares for 1680.32